EF-Education First-Drapac rider Joe Dombrowksi feels there is no clear cut answer to the rights and wrongs of Chris Froome's decision to continue with a normal race program despite the Briton's Adverse Analytical Finding for salbutamol during the 2017 Vuelta a Espana.
The American rider also believes that Froome's case highlights the economic vulnerability of a sport which depends totally on sponsorship deals for financial survival. But at the same time, Dombrowski, a former Team Sky rider, recognises that Froome has the right to race and that not enough is known for the case to be evaluated fully for or against that decision.
"If I was a major corporation, looking at backing cycling , and the biggest rider in the sport is under investigation and racing, and it was not sure whether he's going to get banned and then they are going to have to take away results he's achieved, the whole look is a bit messy if you're trying to sell that," Dombrowski told Cyclingnews.
ADVERTISEMENT
However, he also points that, "I don't really know the details of the case, I don't think anybody apart from Chris and probably some people at Sky do."
"So I guess I don't have a really strong opinion either way. I don't think it's a good look for the sport in general, which is the only reason I'd say I'm not sure it's great that he's racing, but I don't know all the details, I don't know that that's his fault. There's so much we don't know."
Froome's urine sample from an anti-doping control taken after stage 18 of the 2017 Vuelta a Espana was found to have twice the allowed limit of the asthma drug salbutamol. The 32-year-old says he is a life-long asthma sufferer, and insisted that he knows the rules and has never taken more than he is allowed.
Gunning for the Giro d'Italia after a good winter
You can read more at Cyclingnews.com
via Cyclingnews Latest News http://www.cyclingnews.com/news/dombrowski-sees-no-clear-cut-answer-to-chris-froomes-salbutamol-case
No comments:
Post a Comment